FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental medicine. Under ultrasound control by laser of near infrared range with wave length of 1064 nm, power of 7-8 W, non-through microchannels with depth of 3-4 mm are formed in cirrhotic liver by contact coagulation. Microchannels cover the entire affected lobe of the liver, with the exception of the hepatic hilum. 10,000 units/kg of Interleukin-2 is introduced into the hepatic hilum by injection with an insulin syringe.
EFFECT: method enables treating portal hypertension syndrome accompanying hepatic cirrhosis, safely revascularizing the liver after simulating cirrhosis, increasing neoangiogenesis while preserving the contours of the liver lobules.
1 cl, 6 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR SIMULATING EXPERIMENTAL HEPATIC CIRRHOSIS | 2024 | 
 | RU2828542C1 | 
| METHOD OF PHOTODYNAMIC EXPOSURE IN TREATING LOCALIZED CIRCUMSCRIBED PERITONITIS IN EXPERIMENT | 2023 | 
 | RU2834555C1 | 
| METHOD FOR SIMULATING LIVER CIRRHOSIS IN EXPERIMENT | 2023 | 
 | RU2817175C1 | 
| METHOD FOR SIMULATING MINE-BLAST INJURY OF SOFT TISSUES AND PELVIC ORGANS IN LABORATORY ANIMALS | 2024 | 
 | RU2840587C1 | 
| USING LACTITOL AND AN ORAL DOSAGE FORM FOR TREATING AND PREVENTING NON-ALCOHOLIC FATTY LIVER DISEASE | 2018 | 
 | RU2692243C1 | 
| APPLICATION OF CB1 RECEPTOR ANTAGONISTS FOR PREPARATION OF COMPOSITION APPLICABLE FOR TREATMENT OF HEPATIC DISEASES | 2005 | 
 | RU2402328C2 | 
| INDIVIDUAL SUBSTANCES SYNTHESIZED ON BASE OF CHEMICAL INTERACTION OF DISULFIDE-CONTAINING PEPTIDES WITH PURINE OR PYRIMIDINE BASE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND PREPARATIONS BASED ON THEREOF, METHODS OF THEIR USING FOR TREATMENT OF INFECTIOUS DISEASES AND PROPHYLAXIS OF COMPLICATIONS | 2001 | 
 | RU2178710C1 | 
| DRUG FOR GASTROINTESTINAL TRACT AND HEPATOBILIARY SYSTEM DISEASES TREATMENT AND PREVENTING RECRUDESCENCES | 2017 | 
 | RU2651711C1 | 
| AGENT FOR ALCOHOLIC TOXICOSIS | 2011 | 
 | RU2493867C2 | 
| METHOD OF TREATMENT OF AUTOIMMUNE GENERAL DISEASES AND MEDICAL PRODUCT | 2007 | 
 | RU2361588C2 | 
Authors
Dates
2025-03-17—Published
2024-09-17—Filed